Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 9, 1998

View Archived Issues

Company Profile: PolyMASC

CNS-5161 shows efficacy in phase I trial

Barr receives additional generic approval

Cell Therapeutics and City of Hope join forces for diabetes research

Second-generation CMV retinitis compound enters phase I/II

Beaufour Ipsen to market Tanabe ACE inhibitor

Serotone introduced in China

Ares-Serono's recombinant IFN-beta1a recommended for approval by CPMP for MS

MycoTox's antifungal program advances

New rationale elucidated for clinical evaluation of GW-506U in refractory hematologic malignancies

ADCON-L submitted to regulatory authorities

Report of ThromboSol efficacy presented at hematology congress

Genetronics' electroporation therapy further evaluated in French trial

Genentech licenses TPO to Pharmacia & Upjohn

Thrombin inhibitors reported by BMS

Novel diagnostic compositions reported by Amersham

New antiviral agents emerge from European research collaboration

HCAP discovered by Incyte; potential treatment for obesity

New therapeutic protein reported by Amgen

New phosphatase inhibitors from the University of Pittsburgh

Merck discloses novel D4 receptor ligands

Epix Medical's MRI contrast agent evaluated for breast cancer indications

NIH announces contemplation of licensing agreement for growth factors

NIH communication reports contemplation of licensing agreement

NIH seeks CRADA partners or licensees for 12-LO metabolite

New antiulcer agent now available in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...